Treatment of adjuvant-induced arthritis with the combination of methotrexate and probiotic bacteria escherichia coli o83 (colinfant®)

Folia Microbiologica

Volumn 54, Issue 4, 2009, Pages 359-363

  Rovensky J ^a   Stancikova M ^a   Svik K ^a   Uteseny J ^b   Bauerova K ^c   Jurcovicova J ^d  

^a NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^c INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^d INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; METHOTREXATE; PROBIOTIC AGENT;

ANIMAL; ARTHRITIS; ARTICLE; DISEASE MODEL; ESCHERICHIA COLI; HUMAN; IMMUNOLOGY; LEWIS RAT; MALE; MULTIMODALITY CANCER THERAPY; PHYSIOLOGY; RAT;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; HUMANS; MALE; METHOTREXATE; PROBIOTICS; RATS; RATS, INBRED LEW;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; RATTUS;

EID: 70350359297     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12223-009-0045-2     Document Type: Article

References (27)

1. Cebra J.J.: Influences of microbiota on intestinal immune system development. Am.J.Clin.Nutr. 69, 1046-1051(1999).
2. Connolly K.M., Stecher V.J., Danis E., Pruden D.J., Labrie T.: Alteration of interleukin-1 production and the acute phase response following medication of adjuvant arthritic rats with cyclosporin-A or methotrexate. Internat.J.Immunopharmacol. 10, 717-728 (1988a).
3. Connolly K.M., Stecher V.J., Labrie T., Fluno C.: Modulation of the acute phase response and in vitro measurement of interleukin-1 activity following administration of dexamethasone to adjuvant-arthritic rats. Immunopharmacology 15, 133-142 (1988b).
4. Eerola E., Möttö T., Hannonen P., Luukkainen R., Kantola I., Vuori K., Tuominen J., Toivanen P.: Intestinal flora in early rheumatoid arthritis. Brit.J.Rheumatol. 33, 1030-1038 (1994).
5. Hatakka K., Martio J., Korpela M., Herranen M., Poussa T., Laasanen T., Saxelin M., Vapaatalo H., Moilanen E., Korpela R.: Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis - a pilot study. Scand. J.Rheumatol. 32, 211-215 (2003).
6. Hoekstra M., VAN Ede A.E., Haadsma C.J., VAN DE Laar M.A.F.J., Huizinga T.W.J., Kruijsen M.V.M., Laan R.F.J.M.: Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis. Ann.Rheum.Dis. 62, 423-426 (2003).
7. Hudcovic T., Štěpánková R., Kozáková H., Hrnčíř T., Tlaskalová-Hogenová H.: Effects of monocolonization with Escherichia coli strains O6K13 and Nissle 1917 on the development of experimentally induced acute and chronic intestinal inflammation in germ-free immunocomponent and immunodeficient mice. Folia Microbiol. 52, 618-626 (2007).
8. Isolauri E., Sütas Y., Kankaanpää P., Arvilommi H., Salminen S.: Probiotics: effect on immunity. Am.J.Clin.Nutr. 73(Suppl.), 444S-450S (2001).
9. Kano H., Kaneko T., Kaminogawa S.: Oral intake of Lactobacillus delbrueckii subsp. bulgaricus OLL1073R-1 prevents collagen-induced arthritis in mice. J.Food Prot. 65, 153-160 (2002).
10. Kocourková I., Žádniková R., Žižka J., Rosová V.: Effect of oral application of a probiotic E. coli strain on the intestinal microflora of children of allergic mothers during the first year of life. Folia Microbiol. 52, 189-193 (2007).
11. Kokešová A., Frolová L., Kverka M., Sokol D., Rossmann P., Bártová J., Tlaskalová-Hogenová H.: Oral administration of probiotic bacteria (E. coli Nissle, E. coli O83, Lactobacillus casei) influences the severity of dextran sodium sulfate-induced colitis in BALB/c mice. Folia Microbiol. 51, 478-484 (2006).
12. Koninkx J.F., Malago J.J.: The protective potency of probiotic bacteria and their microbial products against enteric infections - review. Folia Microbiol. 53, 189-194 (2008).
13. Lodinová-Žádniková R., Sonnenborn U.: Efect of preventive administration of non-pathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants. Biol.Neonate 71, 224-232 (1997).
14. Lodinová-Žádniková R., Cukrowska B., Tlaskalová-Hogenová H.: Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years). Internat.Arch.Allergy Immunol. 131, 209-211 (2003).
15. Malin M., Verronen P., Korhonen A.: Dietary therapy with Lactobacillus GG, bovine colostrum or bovine immune colostrum in patients with juvenile chronic arthritis: evaluation of effect on gut defense mechanism. Inflammopharmacology 5, 219-236 (1997).
16. Mao Y., Nobaek S., Kasravi B., Adawi D., Stenram U., Molin G., Jeppsson B.: The effect of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats. Gastroenterology 111, 334-344 (1996).
17. McDougall J., Bruce B., Spiller G., Westerdahl J., McDougall M.: Effects of a very low fat, vegan diet in subjects with rheumatoid arthritis. J.Altern.Complement.Med. 8, 71-75 (2002).
18. Papaconstantinou H.T., Xie C., Zhang W., Ansari N.H., Hellmich M.R., Townsend C.M. Jr., Ko T.C.: The role of caspases in methotrexate-induced gastrointestinal toxicity. Surgery 130, 859-865 (2001).
19. Peltonen R., Nenonen M., Helve T., Hanninen O., Toivanen P., Eerola E.: Fecal microbial flora and disease activity in rheumatoid arthritis during a vegan diet. Brit.J.Rheumatol. 36, 64-68 (1997).
20. Reid G., Jass J., Sebulsky M.T., McCormick J.K.: Potential uses of probiotics in clinical practice. Clin.Microbiol.Rev. 16, 658-672 (2003).
21. Rovenský J., Švík K., Stančíková M., Ištok R., Ebringer L., Ferenčík M.: Treatment of experimental adjuvant arthritis with the combination of methotrexate and lyophilized Enterococcus faecium enriched with organic selenium. Folia Microbiol. 47, 573-578 (2002).
22. Rovenský J., Švík K., Matha V., Ištok R., Kamarád V., Ebringer L., Ferenčík M., Stančíková M.: Combination treatment of rat adjuvant-induced arthritis with methotrexate, probiotic bacteria Enterococcus faecium, and selenium. Ann.N.Y.Acad.Sci. 1051, 570-581 (2005).
23. Sartor R.B.: Role of enteric microflora in the pathogenesis of intestinal inflammation and arthritis - review. Aliment.Pharmacol.Ther. 11, 17-32 (1997).
24. So J.S., Kwon H.K., Lee C.G., Yi H.J., Park J.A., Lim S.Y., Hwang K.C., Jeon Y.H., Im S.H.: Lactobacillus casei suppresses experimental arthritis by down-regulating T helper 1 effector functions. Mol.Immunol. 45, 2690-2699 (2008).
25. Tlaskalová-Hogenová H., Štěpánková R., Hudcovic T., Tučková L., Cukrowska B., Lodinová-Žádníková R., Kozáková H., Rossmann P., Bártová J., Sokol D., Funda D.P., Borovská D., Řeháková Z., Šinkora J., Hofman J., Drastich P., Kokešová A.: Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol.Lett. 93, 97-107 (2004).
26. Welles W.L., Silkworth J., Oronsky A.L., Kerwar S.S., Galivan J.: Studies on the effect of low dose methotrexate in adjuvant arthritis. J.Rheumatol. 12, 904-906 (1985).
27. Wooley P.H.: Animal models of rheumatoid arthritis. Curr.Opin.Rheumatol. 3, 407-420 (1991).